Abstract
Background Mild cognitive impairment (MCI) is an intermediate stage of cognitive decline fitting in-between normal cognition and dementia. With the growing aging population, this study aimed to develop and psychometrically validate an android-based application for early MCI detection in elderly subjects.
Method This study was conducted in two phases, including 1-Initial design and prototyping of the application named M-Check, 2-psychometric evaluation. After the design and development of the M-Check app, it was evaluated by experts and elderly subjects. Face validity was determined by two checklists provided to the expert panel and the elderly subjects. Convergent validity of the M-Check app was assessed using the Montreal Cognitive Assessment (MoCA) battery through Pearson correlation. Test-retest and internal consistency and reliability were evaluated using Intra-Class Correlation (ICC) and Kuder-Richardson coefficients, respectively. In addition, the usability was assessed by a System Usability Scale (SUS) questionnaire. SPSS 16.0 was employed to analyze the data.
Result The app’s usability assessment by elderlies and experts scored 77.11 and 82.5, respectively. Also, the correlation showed that the M-Check app was negatively correlated with the MoCA test (r = -0.71, p <0.005), and the ICC was more than 0.7. Moreover, the Richardson’s Coder coefficient was 0.82, corresponding to an acceptable reliability.
Conclusion In this study, we validated the M-Check app for the detection of MCI based on the growing need for cognitive assessment tools that can identify early decline. Such screeners are expected to take much shorter time than typical neuropsychological batteries do. Additional work are yet to be underway to ensure that M-Check is ready to launch and used without the presence of a trained person.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a research grant received from Shiraz University of Medical Sciences (grant number: 97-01-07-17037).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This work was supported by a research grant received from Shiraz University of Medical Sciences (grant number: 97-01-07-17037).
The study was approved by the Ethics Committee of Shiraz University of Medical Sciences (IR.SUMS.REC.1397.715). All participants submitted written informed consents prior to enrollment and were entitled to quit the study process anytime upon their discretion.
Data Availability
Authors confirm the availability of all data referred to in the manuscript.
